ClearPoint Neuro (CLPT) Competitors $10.70 +0.46 (+4.50%) Closing price 03:59 PM EasternExtended Trading$10.70 -0.01 (-0.06%) As of 04:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CLPT vs. BLFS, MDXG, ESTA, PLSE, INMD, IRMD, TNDM, KMTS, EMBC, and SIBNShould you be buying ClearPoint Neuro stock or one of its competitors? The main competitors of ClearPoint Neuro include BioLife Solutions (BLFS), MiMedx Group (MDXG), Establishment Labs (ESTA), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), Tandem Diabetes Care (TNDM), Kestra Medical Technologies (KMTS), Embecta (EMBC), and SiBone (SIBN). These companies are all part of the "medical equipment" industry. ClearPoint Neuro vs. Its Competitors BioLife Solutions MiMedx Group Establishment Labs Pulse Biosciences InMode iRadimed Tandem Diabetes Care Kestra Medical Technologies Embecta SiBone ClearPoint Neuro (NASDAQ:CLPT) and BioLife Solutions (NASDAQ:BLFS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Is CLPT or BLFS more profitable? BioLife Solutions has a net margin of -5.39% compared to ClearPoint Neuro's net margin of -66.15%. BioLife Solutions' return on equity of 0.16% beat ClearPoint Neuro's return on equity.Company Net Margins Return on Equity Return on Assets ClearPoint Neuro-66.15% -94.44% -51.58% BioLife Solutions -5.39%0.16%0.14% Do analysts prefer CLPT or BLFS? ClearPoint Neuro currently has a consensus price target of $19.67, suggesting a potential upside of 83.78%. BioLife Solutions has a consensus price target of $31.29, suggesting a potential upside of 20.87%. Given ClearPoint Neuro's higher probable upside, research analysts plainly believe ClearPoint Neuro is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ClearPoint Neuro 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13 Do institutionals and insiders hold more shares of CLPT or BLFS? 30.1% of ClearPoint Neuro shares are owned by institutional investors. Comparatively, 93.2% of BioLife Solutions shares are owned by institutional investors. 7.0% of ClearPoint Neuro shares are owned by company insiders. Comparatively, 2.2% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media favor CLPT or BLFS? In the previous week, BioLife Solutions had 2 more articles in the media than ClearPoint Neuro. MarketBeat recorded 6 mentions for BioLife Solutions and 4 mentions for ClearPoint Neuro. BioLife Solutions' average media sentiment score of 1.52 beat ClearPoint Neuro's score of 0.02 indicating that BioLife Solutions is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ClearPoint Neuro 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral BioLife Solutions 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has preferable earnings and valuation, CLPT or BLFS? ClearPoint Neuro has higher earnings, but lower revenue than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than ClearPoint Neuro, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearPoint Neuro$31.39M9.69-$18.91M-$0.81-13.21BioLife Solutions$82.25M15.07-$20.18M-$0.12-215.69 Which has more risk and volatility, CLPT or BLFS? ClearPoint Neuro has a beta of 0.85, meaning that its stock price is 15% less volatile than the S&P 500. Comparatively, BioLife Solutions has a beta of 1.76, meaning that its stock price is 76% more volatile than the S&P 500. SummaryBioLife Solutions beats ClearPoint Neuro on 13 of the 17 factors compared between the two stocks. Get ClearPoint Neuro News Delivered to You Automatically Sign up to receive the latest news and ratings for CLPT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CLPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLPT vs. The Competition Export to ExcelMetricClearPoint NeuroMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$304.23M$7.05B$5.83B$9.73BDividend YieldN/A1.30%3.84%4.09%P/E Ratio-13.2127.1831.1625.99Price / Sales9.69145.15474.86122.97Price / CashN/A21.6837.1558.38Price / Book15.516.869.116.38Net Income-$18.91M$176.42M$3.26B$265.56M7 Day Performance-7.35%0.49%2.06%1.89%1 Month Performance-4.63%-0.52%5.08%1.23%1 Year Performance-5.88%13.05%31.26%21.10% ClearPoint Neuro Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLPTClearPoint Neuro1.914 of 5 stars$10.70+4.5%$19.67+83.8%-14.1%$304.23M$31.39M-13.21110BLFSBioLife Solutions2.7754 of 5 stars$22.37-1.4%$31.29+39.9%-2.5%$1.09B$82.25M-186.40440News CoverageInsider TradeHigh Trading VolumeMDXGMiMedx Group3.2312 of 5 stars$7.04+0.3%$12.00+70.5%+7.0%$1.04B$348.88M33.53870ESTAEstablishment Labs1.9614 of 5 stars$33.63-3.4%$55.80+65.9%-9.2%$1.01B$166.02M-11.031,018News CoverageAnalyst ForecastHigh Trading VolumePLSEPulse Biosciences3.6621 of 5 stars$14.88+1.2%$22.00+47.8%-26.7%$989.60M$700K0.00140INMDInMode2.0206 of 5 stars$13.80-2.2%$18.04+30.7%-11.2%$891.88M$394.82M5.59480IRMDiRadimed4.6124 of 5 stars$70.00+0.1%$72.00+2.9%+56.9%$889.51M$73.24M43.21110TNDMTandem Diabetes Care4.5442 of 5 stars$10.11-10.0%$22.67+124.2%-74.1%$758.80M$940.20M-3.272,650Positive NewsAnalyst ForecastKMTSKestra Medical TechnologiesN/A$14.65+0.9%$27.33+86.6%N/A$745.58M$59.81M0.00300EMBCEmbecta4.8383 of 5 stars$12.73+3.7%$19.00+49.3%+3.0%$717.67M$1.12B8.902,100High Trading VolumeSIBNSiBone4.1781 of 5 stars$15.40-1.8%$23.67+53.7%+3.6%$676.45M$167.18M-27.50350News CoverageInsider Trade Related Companies and Tools Related Companies BioLife Solutions Competitors MiMedx Group Competitors Establishment Labs Competitors Pulse Biosciences Competitors InMode Competitors iRadimed Competitors Tandem Diabetes Care Competitors Kestra Medical Technologies Competitors Embecta Competitors SiBone Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CLPT) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ClearPoint Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ClearPoint Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access